Trials / Completed
CompletedNCT04707963
Peanut Protein Supplementation to Augment Muscle Growth and Improve Markers of Muscle Quality and Health in Young Adults
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 56 (actual)
- Sponsor
- Auburn University · Academic / Other
- Sex
- All
- Age
- 18 Years – 30 Years
- Healthy volunteers
- Accepted
Summary
This study will evaluate the adaptations in skeletal muscle that occur in response to 10 weeks of weight training with or without peanut protein supplementation in untrained men and women ages 18-30
Detailed description
This is a two-phase study using both novel and conventional methods to assess how PP supplementation affects muscle tissue in young adults who engage in resistance training. These two phases will be conducted as part of a 10-week randomized controlled trial in which men and women aged 18-30 years (n=40), will be stratified by gender and randomized to a resistance training intervention (whole body, two days per week) with PP powder (72g daily; n=10 males, n=10 females) provided during the intervention (immediate group, IG) or after the intervention (wait-list control, WLC, n=10 males, n=10 females). The aims of this study are to determine the acute (deuterium oxide tracer) and chronic (peripheral quantitative computed tomography) effects of PP during resistance training on skeletal muscle myofibrillar protein synthesis rates, changes in skeletal muscle size and quality, changes in whole and appendicular body composition (dual energy x-ray absorptiometry), changes in inflammatory markers and the fecal microbiome.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Peanut protein powder | Peanut protein powder will be provided to participants who will be instructed to consume 72g daily, mixed with water |
| BEHAVIORAL | Full body resistance training | Participants will undergo supervised resistance training two times per week (5 exercises, 3 sets of 8-12 repetitions per set) |
Timeline
- Start date
- 2021-02-06
- Primary completion
- 2021-05-31
- Completion
- 2021-05-31
- First posted
- 2021-01-13
- Last updated
- 2021-06-09
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT04707963. Inclusion in this directory is not an endorsement.